Project

Moleculen

MG3HB

Our unilateral diet has resulted in a deficiency of specific elements needed for the well-functioning of the human body. Especially magnesium is low in our processed food. It has been recognized that magnesium plays an important role in cognition and positively affects sleep and calmness (anti-stress). Commercially available magnesium supplements (magnesiumoxide, and magnesium citrate glycerophosphate, etc.) are claiming the above-described and are available at supermarkets, groceries, and webshops.

However, the bioavailability, the amount of magnesium entering the bloodstream, is still rather low. Furthermore, value would be created if the organic acid coupled to magnesium not only functions as a carrier but also is biologically active (dual ligand). Our magnesium supplement (Magnesium (R)-3-hydroxybutyrate) combines the activity of magnesium with a biologically active organic acid ((R)-3-hydroxybutyrate), a natural compound (ketone body) that results in energy and also positively influences several processes in our body. Preliminary in vivo studies have shown high bioavailability (better than magnesium citrate and glycerophosphate). Our compound can be efficiently prepared from glucose/xylose using a fermentative/chemical route, resulting in an acceptable cost price.

This project is aimed to optimize and scale up the synthesis of our target magnesium supplement, start with a novel food application, and perform a market study to further study its market potential.

Project team

André Heeres

Project Number

BIOB24020

Year granted

2024

Applicant

Hanze University of Applied Sciences

Funding

€ 200.000

Sector/Industry

SDG's

Thematic Cluster

TC2: Agriculture & Food
Molecuul

2024

Year granted

Hanze University of Applied Sciences

Applicant

€ 200.000

Project funded

Biotech Booster and CSL join forces to support biotech projects

Biotech Booster and CSL have taken a significant step towards accelerating biotech innovations. The organizations signed a collaboration agreement to

Biotech Booster and CSL join forces to support biotech projects

Three members from Biotech Booster projects receive personal grant by the Faculty of Impact

Congratulations to Fleur van Eeden, Dr. Brigit van Brenk, and Dr. Carina Nieuwenweg for receiving a personal grant by the

Three members from Biotech Booster projects receive personal grant by the Faculty of Impact
biotechnology netherlands

Meet EXIT071: advancing exosome isolation technology

Meet EXIT071, part of the first batch of Proof-of-Concept projects that joined the Biotech Booster program after the round of

Meet EXIT071: advancing exosome isolation technology

T-Guard receives approval to launch first-in-human trials

T-Guard is a Biotech Booster project addressing a significant unmet medical need in systemic sclerosis, a severe and debilitating autoimmune

T-Guard receives approval to launch first-in-human trials

Introducing Lieve van Veggel

In this series “Meet the people behind Biotech Booster” we introduce you to the passionate people who are involved in

Introducing Lieve van Veggel

Biotech Booster’s Annual Event 2025

On March 13th we had the privilege of hosting the second Annual Event of Biotech Booster at the AFAS Theater

Biotech Booster’s Annual Event 2025
Citaat

Biotech Booster helps us through funding and by providing us with a network to validate where we can make the best impact with our new analysis device.

Biotechnology netherlands

Carlos de Lannoy

Constellate

Citaat

What we look forward to most is leveraging the extraordinary network of Biotech Booster that we need to get foot in the market, get know-how, and understanding the competitive field which is necessary for setting up successful operations.

Biotechnology netherlands

Pim Schaasberg & Martin Pabst

ProteoT

Moleculen

Newsletter

Receive monthly updates about our community!

Subscribe to our newsletter